中國水業集團(01129.HK)擬折讓約16.67%配售3.19億股 籌資7760萬港元
格隆匯1月27日丨中國水業集團(01129.HK)發佈公吿,於2022年1月27日,公司與配售代理訂立配售協議,公司擬按每股配售股份0.25港元(較1月27日收市價每股0.30港元折讓約16.67%)向目前預期不少於六名承配人配售最多3.19億股配售股份,相當於現有已發行股本約19.99%;經配發及發行配售股份擴大後公司已發行股本約16.66%。
配售事項所得款項淨額估計約7760萬港元,預期配售事項的所得款項淨額將用作償還集團部分貸款及應計利息及/或集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.